Robert F Kennedy Jr's first confirmation hearing was a fractious affair, marked by tough questions about his prior ...

In Part 6 of the Life Sciences Industry Report, we’ve collated key thought leadership from 2024 that looks at ways in which ...

Weber said it is the right time to appoint a successor, given the company's "competitive growth outlook, new product launches ...

One explanation for the findings is that ECG data can help to predict the risk of stroke, which can contribute to age-related ...

President Trump will continue to pursue the policy of Medicare pricing negotiation introduced by former President Biden's Inflation Reduction Act (IRA), but will look at refining the programme.

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now producing increasingly personalised and sophisticated therapies, ...

The growing use of AI has opened new avenues for healthcare marketers, revolutionising how they approach new initiatives. With the Pharma 4.0 term representing the pharmaceutical industry's adaptation ...

In a new pharmaphorum podcast with ZS Associates’ Sharon Karlsberg, principal and leader of oncology solutions, and Brandi Davis-Dusenbery, principal and partner, web editor Nicole Raleigh explores ...

Misinformation is becoming more prevalent with the rise of unregulated social media content. Combatting this and helping men distinguish between credible sources and misleading or false information is ...

Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of ...

A century-in-the-making pandemic was on its way and we, in the live marketing industry – like everyone – were pretty much ...

Artificial intelligence start-up Quibim has raised $50 million in first-round financing to support the rollout of its ...